Clinical Trial Update: Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating weekly oral RAD001 (everolimus) in combination with oral topotecan for advanced or recurrent endometrial cancer; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Everolimus (RAD001) (everolimus)
• Topotecan (topotecan)

Snippet

Sponsor: Yale University | Conditions: Endometrial Cancer | Phase 1 | Status: COMPLETED